CLX
Income statement / Annual
Last year (2025), The Clorox Company's total revenue was $7.10 B,
an increase of 0.16% from the previous year.
In 2025, The Clorox Company's net income was $810.00 M.
See The Clorox Company,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
| Operating Revenue |
$7.10 B |
$7.09 B |
$7.39 B |
$7.11 B |
$7.34 B |
$6.72 B |
$6.21 B |
$6.12 B |
$5.97 B |
$5.76 B |
| Cost of Revenue |
$3.91 B
|
$4.07 B
|
$4.52 B
|
$4.62 B
|
$4.16 B
|
$3.67 B
|
$3.50 B
|
$3.46 B
|
$3.31 B
|
$3.16 B
|
| Gross Profit |
$3.19 B
|
$3.03 B
|
$2.87 B
|
$2.49 B
|
$3.18 B
|
$3.05 B
|
$2.71 B
|
$2.66 B
|
$2.67 B
|
$2.60 B
|
| Gross Profit Ratio |
0.45
|
0.43
|
0.39
|
0.35
|
0.43
|
0.45
|
0.44
|
0.44
|
0.45
|
0.45
|
| Research and Development Expenses |
$121.00 M
|
$126.00 M
|
$138.00 M
|
$132.00 M
|
$149.00 M
|
$145.00 M
|
$136.00 M
|
$132.00 M
|
$135.00 M
|
$141.00 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.89 B
|
$1.98 B
|
$1.91 B
|
$1.66 B
|
$1.79 B
|
$1.64 B
|
$1.47 B
|
$1.41 B
|
$1.41 B
|
$1.39 B
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.02 B
|
$2.11 B
|
$2.04 B
|
$1.80 B
|
$1.94 B
|
$1.79 B
|
$1.60 B
|
$1.54 B
|
$1.54 B
|
$1.53 B
|
| Cost And Expenses |
$5.93 B
|
$6.18 B
|
$6.56 B
|
$6.41 B
|
$6.10 B
|
$5.46 B
|
$5.11 B
|
$5.00 B
|
$4.85 B
|
$4.69 B
|
| Interest Income |
$9.00 M
|
$23.00 M
|
$16.00 M
|
$5.00 M
|
$5.00 M
|
$2.00 M
|
$3.00 M
|
$6.00 M
|
$4.00 M
|
$5.00 M
|
| Interest Expense |
$101.00 M
|
$103.00 M
|
$103.00 M
|
$97.00 M
|
$93.00 M
|
$93.00 M
|
$91.00 M
|
$79.00 M
|
$82.00 M
|
$82.00 M
|
| Depreciation & Amortization |
$219.00 M
|
$235.00 M
|
$236.00 M
|
$224.00 M
|
$210.00 M
|
$179.00 M
|
$182.00 M
|
$167.00 M
|
$163.00 M
|
$165.00 M
|
| EBITDA |
$1.40 B |
$736.00 M |
$577.00 M |
$928.00 M |
$1.20 B |
$1.46 B |
$1.30 B |
$1.29 B |
$1.28 B |
$1.23 B |
| EBITDA Ratio |
0.2
|
0.1
|
0.08
|
0.13
|
0.16
|
0.22
|
0.21
|
0.21
|
0.21
|
0.21
|
| Operating Income Ratio |
0.17
|
0.13
|
0.11
|
0.1
|
0.17
|
0.19
|
0.18
|
0.18
|
0.19
|
0.19
|
| Total Other Income/Expenses Net |
-$101.00 M
|
-$518.00 M
|
-$589.00 M
|
-$89.00 M
|
-$338.00 M
|
-$80.00 M
|
-$83.00 M
|
-$71.00 M
|
-$89.00 M
|
-$85.00 M
|
| Income Before Tax |
$1.08 B
|
$398.00 M
|
$238.00 M
|
$607.00 M
|
$900.00 M
|
$1.19 B
|
$1.02 B
|
$1.05 B
|
$1.03 B
|
$983.00 M
|
| Income Before Tax Ratio |
0.15
|
0.06
|
0.03
|
0.09
|
0.12
|
0.18
|
0.16
|
0.17
|
0.17
|
0.17
|
| Income Tax Expense |
$254.00 M
|
$106.00 M
|
$77.00 M
|
$136.00 M
|
$181.00 M
|
$246.00 M
|
$204.00 M
|
$231.00 M
|
$330.00 M
|
$335.00 M
|
| Net Income |
$810.00 M
|
$280.00 M
|
$149.00 M
|
$462.00 M
|
$710.00 M
|
$939.00 M
|
$820.00 M
|
$823.00 M
|
$701.00 M
|
$648.00 M
|
| Net Income Ratio |
0.11
|
0.04
|
0.02
|
0.07
|
0.1
|
0.14
|
0.13
|
0.13
|
0.12
|
0.11
|
| EPS |
6.56 |
2.25 |
1.21 |
3.75 |
5.65 |
7.46 |
6.42 |
6.37 |
5.43 |
5.01 |
| EPS Diluted |
6.52 |
2.25 |
1.2 |
3.73 |
5.58 |
7.35 |
6.32 |
6.25 |
5.33 |
4.92 |
| Weighted Average Shares Out |
$123.53 M
|
$124.17 M
|
$123.59 M
|
$123.11 M
|
$125.57 M
|
$125.83 M
|
$127.73 M
|
$129.29 M
|
$128.95 M
|
$129.47 M
|
| Weighted Average Shares Out Diluted |
$124.29 M
|
$124.80 M
|
$124.18 M
|
$123.91 M
|
$127.30 M
|
$127.67 M
|
$129.79 M
|
$131.58 M
|
$131.57 M
|
$131.72 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
